Citi raises Ultragenyx Pharma price target to $32

September 18, 2026 5:17 AM

Citi analyst Yigal Nochomovitz raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $32.00 from $31.00, while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found